Literature DB >> 19233584

Synchrotron-based intra-venous K-edge digital subtraction angiography in a pig model: a feasibility study.

Elisabeth Schültke1, Stefan Fiedler, Christian Nemoz, Lissa Ogieglo, Michael E Kelly, Paul Crawford, Francois Esteve, Thierry Brochard, Michel Renier, Herwig Requardt, Geraldine Le Duc, Bernhard Juurlink, Kotoo Meguro.   

Abstract

BACKGROUND: K-edge digital subtraction angiography (KEDSA) combined with the tunability of synchrotron beam yields an imaging technique that is highly sensitive to low concentrations of contrast agents. Thus, contrast agent can be administered intravenously, obviating the need for insertion of a guided catheter to deliver a bolus of contrast agent close to the target tissue. With the high-resolution detectors used at synchrotron facilities, images can be acquired at high spatial resolution. Thus, the KEDSA appears particularly suited for studies of neurovascular pathology in animal models, where the vascular diameters are significantly smaller than in human patients.
MATERIALS AND METHODS: This feasibility study was designed to test the suitability of KEDSA after intravenous injection of iodine-based contrast agent for use in a pig model. Four adult male pigs were used for our experiments. Neurovascular angiographic images were acquired using KEDSA with a solid state Germanium (Ge) detector at the European Synchrotron Radiation Facility (ESRF) in Grenoble, France.
RESULTS: After intravenous injection of 0.9 ml/kg iodinated contrast agent (Xenetix), the peak iodine concentrations in the internal carotid and middle cerebral arteries reached 35 mg/ml. KEDSA images in radiography mode allowed the visualization of intracranial arteries of less than 1.5mm diameter. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233584     DOI: 10.1016/j.ejrad.2009.01.019

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

1.  Model and reconstruction of a K-edge contrast agent distribution with an X-ray photon-counting detector.

Authors:  Bo Meng; Wenxiang Cong; Yan Xi; Bruno De Man; Jian Yang; Ge Wang
Journal:  Opt Express       Date:  2017-04-17       Impact factor: 3.894

2.  Optimization of K-edge imaging with spectral CT.

Authors:  Peng He; Biao Wei; Wenxiang Cong; Ge Wang
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

3.  Energy-discriminative performance of a spectral micro-CT system.

Authors:  Peng He; Hengyong Yu; James Bennett; Paul Ronaldson; Rafidah Zainon; Anthony Butler; Phil Butler; Biao Wei; Ge Wang
Journal:  J Xray Sci Technol       Date:  2013       Impact factor: 1.535

4.  In vivo imaging of rat coronary arteries using bi-plane digital subtraction angiography.

Authors:  Cristian T Badea; Laurence W Hedlund; Yi Qi; Brian Berridge; G Allan Johnson
Journal:  J Pharmacol Toxicol Methods       Date:  2011-06-13       Impact factor: 1.950

5.  Preliminary experimental results from a MARS Micro-CT system.

Authors:  Peng He; Hengyong Yu; Patrick Thayer; Xin Jin; Qiong Xu; James Bennett; Rachael Tappenden; Biao Wei; Aaron Goldstein; Peter Renaud; Anthony Butler; Phillip Butler; Ge Wang
Journal:  J Xray Sci Technol       Date:  2012       Impact factor: 1.535

Review 6.  Synchrotron radiation in cancer treatments and diagnostics: an overview.

Authors:  S Gil; M Fernández; Y Prezado; A Biete; A Bravin; M Sabés
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

7.  Real time observation of mouse fetal skeleton using a high resolution X-ray synchrotron.

Authors:  Dong Woo Chang; Bora Kim; Jae Hoon Shin; Young Min Yun; Jung Ho Je; Yeu Kuang Hwu; Jung Hee Yoon; Je Kyung Seong
Journal:  J Vet Sci       Date:  2011-06       Impact factor: 1.672

8.  Spectroscopic (multi-energy) CT distinguishes iodine and barium contrast material in MICE.

Authors:  N G Anderson; A P Butler; N J A Scott; N J Cook; J S Butzer; N Schleich; M Firsching; R Grasset; N de Ruiter; M Campbell; P H Butler
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.